News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Vapourtec Pump Key to Tamoxifen Breakthrough


9/9/2013 10:07:10 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SUFFOLK, United Kingdom--(BUSINESS WIRE)--A recent academic paper published in the journal Organic Process Research and Development by the Group of Prof Steven V. Ley, Department of Chemistry, University of Cambridge (UK) outlines a breakthrough on the manufacture of breast cancer drug Tamoxifen involving flow chemistry technology developed by UK specialist chemical engineering firm Vapourtec. A prominent feature in the success of the research carried out, profiled in the article “Continuous flow-processing of organometallic reagents using an advanced peristaltic pumping system and the telescoped flow synthesis of (E/Z)-tamoxifen”, was the use of Vapourtec’s E-Series flow chemistry system that enables the processing of organometallic reagents.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES